N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.

相似書籍

• Protection from Doxorubicin-Induced Cardiomyopathy Using the Modified Anthracycline N-Benzyladriamycin-14-valerate (AD 198)
  由: Cai, Chun, et al.
  出版: (2010)
• Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
  由: Kamath, N., et al.
  出版: (1993)
• Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
  由: Ganapathi, R., et al.
  出版: (1988)
• Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
  由: Christowitz, Claudia, et al.
  出版: (2019)
• N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
  由: Edwards, Shanique K E, et al.
  出版: (2013)